Kennedy's surgery may be followed by experimental therapy

Legendary Duke neurosurgeon Dr. Allan Friedman is scheduled to remove Senator Ted Kennedy's brain tumor this morning, and there's already significant speculation that the lawmaker will undergo experimental therapy in a follow-up treatment. According to a statement, the Duke neurosurgeon will surgically remove the tumor and the senator will undergo radiation and chemotherapy to combat the glioblastoma. About half of all glioblastoma patients die within a year of surgery. Median survival time is 12 to 15 months.

Kennedy, though, is in the hands of the countries best neuro-oncologists. In addition to the chemo drug Temodar, Kennedy may be treated with Avastin. While approved for other cancers, using Avastin to starve the tumor of blood is still only in the experimental stage for brain tumors.

- read the AP report

Suggested Articles

The NIH is starting with Eli Lilly and AbCellera's COVID-19 antibody but could add more prospects as the trial goes on.

The series B positions ex-AveXis executives to build a biotech with a broad gene therapy pipeline and infrastructure to match.

A variant of the ACE2 receptor could work as a COVID-19 therapeutic by drawing the virus away from healthy cells, scientists reported.